Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulators

Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulators

US Patent 10793529 · Granted Oct 6, 2020

Estimated economic value: $48,890,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disor2025
Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disor2025
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevent2024
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevent2024
Rapafucin derivative compounds and methods of use thereof2024
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevent2023
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevent2023
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevent2022
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevent2022
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacycli2021
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacycli2021
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacycli2021